Ulta Beauty To $511? Here Are 5 Other Price Target Changes For Monday

  • Barclays boosted the price target on Ulta Beauty, Inc. ULTA from $491 to $511. Barclays analyst Adrienne Yih maintained an Overweight rating on the stock. Ulta Beauty shares fell 1% to $407.41 in pre-market trading.
  • Wells Fargo boosted Prometheus Biosciences, Inc. RXDX price target from $51 to $71. Wells Fargo analyst Derek Archila maintained an Overweight rating on the stock. Prometheus Biosciences shares fell 2.2% to close at $49.40 on Friday.
  • BMO Capital cut Okta, Inc. OKTA price target from $125 to $110. BMO Capital analyst Keith Bachman maintained an Outperform rating on the stock. Okta shares fell 1.4% to $92.20 in pre-market trading.
  • Piper Sandler raised ShockWave Medical, Inc. SWAV price target from $278 to $338. Piper Sandler analyst Adam Maeder maintained an Overweight rating on the stock. ShockWave Medical shares fell 2.1% to $298.02 in pre-market trading.
  • Raymond James increased The Progressive Corporation PGR price target from $135 to $140. Raymond James analyst C. Gregory Peters maintained an Outperform rating on the stock. Progressive fell 1% to close at $125.16 on Friday.
  • HC Wainwright & Co. increased Verona Pharma plc VRNA price target from $25 to $30. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating on the stock. Verona Pharma shares rose 0.6% to $10.61 in pre-market trading.

Check out this: Fear & Greed Index Moves To 'Fear' Zone As Dow Dips Over 1,000 Points Following Powell's Speech

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsPrice Target Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!